APA (7th ed.) Citation

Makras, P., Yavropoulou, M. P., Anastasilakis, A. D., Papatheodorou, A., & Papapoulos, S. E. (2025). No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: A prospective clinical trial. Osteoporosis International, 36(7), 1231. https://doi.org/10.1007/s00198-025-07538-6

Chicago Style (17th ed.) Citation

Makras, Polyzois, Maria P. Yavropoulou, Athanasios D. Anastasilakis, Athanasios Papatheodorou, and Socrates E. Papapoulos. "No Overshoot of Bone Turnover After Withdrawal of Denosumab Treatment of Adults with Langerhans Cell Histiocytosis: A Prospective Clinical Trial." Osteoporosis International 36, no. 7 (2025): 1231. https://doi.org/10.1007/s00198-025-07538-6.

MLA (9th ed.) Citation

Makras, Polyzois, et al. "No Overshoot of Bone Turnover After Withdrawal of Denosumab Treatment of Adults with Langerhans Cell Histiocytosis: A Prospective Clinical Trial." Osteoporosis International, vol. 36, no. 7, 2025, p. 1231, https://doi.org/10.1007/s00198-025-07538-6.